Innovative Light Probes Allow Real-time Visualization Of Cellular Processes

Fluorescent proteins person revolutionized science, enabling researchers to tag and visualize individual molecules successful surviving cells, tissues, and animals. Using these tools, researchers person watched viruses infect cells successful existent time, observed cellular trash collection, and tracked nan signaling that spurs tumor growth.

Salk scientists and collaborators astatine Albert Einstein College of Medicine person precocious this visualization technology. The caller technology, called visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs), was validated successful aggregate mammalian compartment types and provides a powerful instrumentality for a wide scope of life subject investigation applications.

The study was published successful Nature Methods connected April 22, 2026.

"This activity establishes a versatile level for imaging proteins pinch precocious specificity and minimal background," says co-corresponding writer Axel Nimmerjahn, PhD, professor and Françoise Gilot-Salk Chair astatine Salk. "It opens caller opportunities to study really molecular and cellular processes unfold successful existent clip crossed divers biologic systems."

How tin existent cellular imaging exertion beryllium optimized?

The invention began pinch mini macromolecule fragments called nanobodies, which tin beryllium engineered to hindrance circumstantial macromolecule targets successful surviving cells. When fused to fluorescent proteins, these nanobody-based probes tin uncover wherever target proteins are located and really they behave. However, accepted versions tin still make awesome moreover erstwhile unbound, creating inheritance fluorescence that tin obscure good details.

The Salk and Einstein squad designed a caller type of probe that retains nan targeting powerfulness of nanobodies while greatly reducing inheritance fluorescence. VIS-Fbs go unchangeable and fluorescent only erstwhile bound to their intended target. This binding-dependent ("on-demand") fluorescence reduces inheritance sound by up to astir a hundredfold, enabling overmuch sharper visualization of macromolecule location and dynamics.

In addition, nan researchers developed aggregate versions of this caller probe that fluoresce crossed astir nan full visible spectrum, from bluish to acold red. With this galore colour options, aggregate cellular targets tin beryllium tracked simultaneously. Certain VIS-Fb variants tin besides beryllium switched "on" and "off" pinch light, making it imaginable to travel macromolecule behaviour complete clip pinch precocious spatial and temporal precision. The researchers besides established a modular creation framework, enabling accelerated adjustment of VIS-Fb probes to different targets and functional readouts.

What do scientists study pinch ray probes?

The caller exertion will let scientists to summation much accurate, timely penetration into cellular activity-even successful analyzable environments for illustration surviving encephalon tissue. The researchers demonstrated VIS-Fbs' capabilities crossed a scope of surviving models.

In rodent models, VIS-Fb probes enabled selective labeling and ratiometric imaging of calcium activity successful neurons and astrocytes during behavior. In zebrafish, nan exertion allowed real-time search of move changes during early improvement and successful consequence to narcotics that change signaling pathways.

"Our results show that this imaging level offers a overmuch clearer and much precise position of really proteins behave wrong surviving systems," says co-corresponding writer of nan study Vladislav Verkhusha, PhD, professor and co-director of nan Gruss Lipper Biophotonics Center astatine Albert Einstein College of Medicine. "It opens nan doorway to studying analyzable biologic processes, specified arsenic cell signaling, development, and illness progression, successful caller ways."

Other authors and funding

Other authors see Erin Carey of Salk; Natalia Barykina, Juliana Mendonça-Gomes, and Sofia de Oliveira of nan Albert Einstein College of Medicine; and Olena Oliinyk of nan University of Helsinki.

This study was funded by nan National Institutes of Health (GM122567, NS123719, GM147416), Jane and Aatos Erkko Foundation, Research Council of Finland, Finland Cancer Foundation, Chan Zuckerberg Initiative Foundation, NOMIS Foundation (Salk's Neuroimmunology Initiative), and Edwards-Yeckel Research Foundation.